Clarity Medical Group Holding LimitedHKEX: 1406

Interim report 2025/2026

· Issued by Clarity Medical Group Holding Limited via HKEXnews

Filed with HKEX · Stock code 1406 · · 45 pages · English

Summary by 6ix AI

The report highlights a decrease in revenue compared to the previous year, alongside a significant loss for the period, attributed to ongoing governance issues and increased legal expenses. Despite these challenges, the company remains focused on maintaining service quality and optimizing costs while aiming to resolve outstanding governance matters. The report also includes a breakdown of revenue sources, with refractive treatments being the largest contributor, although this segment saw a decline in revenue.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Clarity Medical Group Holding Limited on 6ix

Earlier from Clarity Medical

Later from Clarity Medical

All Clarity Medical news releases